Dainippon Sumitomo Looks To Expand In Mitochondrial Disease Research, Agrees To Buy U.S. Edison Shares
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharmaceuticals agreed to purchase shares of Edison to promote joint creation of new drug candidate compounds related to intracellular energy metabolism.